Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Central motor conduction as a measure of disease progression in early multiple sclerosis.
Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Clinical applications at ultrahigh field (7 T). Where does it make the difference?
Distress improves after mindfulness training for progressive MS: A pilot randomised trial.
Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis.
White and Gray Matter Volume Changes and Correlation with Visual Evoked Potential in Patients with Optic Neuritis: A Voxel-Based Morphometry Study.
Characteristics, diagnosis and outcome of patients referred to a specialized neurology emergency clinic: prospective observational study.
Intractable nausea and vomiting as presenting manifestation of neuromyelitis optica.
Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica.
Longitudinal T cell-derived IFN-γ/IL-17 balances do not correlate with the disease course in two mouse models of experimental autoimmune encephalomyelitis.
Genome-wide significant association with seven novel multiple sclerosis risk loci.
Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
Validation of mood measures for people with multiple sclerosis.
Highlights from this issue.
Type I interferon in human autoimmunity.
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.
CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
Comprehensive Review of Ocular Angiostrongyliasis with Special Reference to Optic Neuritis.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
Effects of vigorous walking exercise on core body temperature and inhibitory control in thermosensitive persons with multiple sclerosis.
Restless leg syndrome and multiple sclerosis: a case-control study in China.
Pages
« first
‹ previous
…
615
616
617
618
619
620
621
622
623
…
next ›
last »